Skip to main content

Advertisement

Log in

Construction of mTNFR1shRNA plasmid and its biological effects on MHV-3 induced fulminant hepatitis in BALB/cJ mice

  • Published:
Virologica Sinica

Abstract

Previous study on TNFR1-mediated hepatocyte apoptosis has been implicated in the development of fulminant viral hepatitis. To interfere with the potentially effective target, plasmid named p-mTNFR1shRNA complimentary to the sequence responsible for mTNFR1 was also constructed and further confirmed by sequence analysis. To investigate the effect of mTNFR1shRNA plasmid on mTNFR1 expression in vivo and the disease progress in MHV-3 induced fulminant hepatitis mice model. By hydrodynamic injection of mTNFR1shRNA plasmid, the survival rate of mice, hepatic pathological change were examined and compared between mice with/without mTNFR1shRNA plasmid intervention. The expression of mTNFR1 was detected by Real-time PCR, immunohistochemistry staining. The mTNFR1shRNA plasmid significantly reduced mTNFR1 expression in vivo, markedly ameliorates inflammatory infiltration, prolonged the survival time period and elevated the survival rate from 0 up to 13.3% in Balb/cJ mice with MHV-3 induced fulminant hepatitis. This study was designed to explore the opportunity of RNA interference technique in inhibiting TNFR1 expression, which has been reported to be involved in the development of a variety of diseases including fulminant viral hepatitis and severe chronic hepatitis B.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Reference

  1. Barbosa A S, Lin C J. 2004. Gene silencing with RNA interference: a novel tool for the study of physiology and pathophysiology of adrenal cortex. Arq Bras Endocrinol Metabol, 48(5): 612–619.

    PubMed  Google Scholar 

  2. Bang S, Jeong E J, Kim I K, et al. 2000. Fas and tumor necrosis factor-mediated apoptosis uses the same binding surface of FADD to trigger signal transduction. A typical model for convergent signal transduction. J. Biol. Chem. 275: 36217–36222.

    Article  CAS  PubMed  Google Scholar 

  3. Chan F K, Lenardo M J. 2004. A crucial role for p80 TNFR2 in amplifying p60 TNFR1 apoptosis signals in T raves DT. Apoptotic effects of LPS on fibroblasts are indirectly mediated through TNFR1. J Dent Res, 83(9): 671–676.

    Article  Google Scholar 

  4. Cheng V C, Lo C M, Lau G K, et al. 2003. Current issues and treatment of fulminant hepatic failure including transplantation in Hong Kong and the Far East. Semin. Liver Dis, 23, 239–250.

    Article  PubMed  Google Scholar 

  5. Costelli P, Aoki P, Zingaro B, et al. 2003. Mice lacking TNFalpha receptors 1 and 2 are resistant to death and fulminant liver injury induced by agonistic anti-Fas antibody. Cell Death Differ, 10(9): 997–1004.

    Article  CAS  PubMed  Google Scholar 

  6. Elbashir S M, Harborth J, Lendeckel W, et al. 2001. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature, 411 494–498.

    Article  CAS  PubMed  Google Scholar 

  7. Jacque J M, Triques K, Stevenson M. 2002. Modulation of HIV-1 replication by RNA interference. Nature, 418(6896): 435–438.

    Article  CAS  PubMed  Google Scholar 

  8. Kapadia S B, Brideau-Andersen A, Chisari F V. 2003. Interference of hepatitis C virus RNA replication by short interfering RNAs. Proc Natl Acad Sci USA, 100: 2014–2018.

    Article  CAS  PubMed  Google Scholar 

  9. Ledgerwood E C, Pober J S, Bradley J R. 1999. Recent advances in the molecular basis of TNF signal trans- duction. Lab. Invest. 79: 1041–1050.

    CAS  PubMed  Google Scholar 

  10. Nagaki M, Iwai H, Naiki T, et al. 2000. High levels of serum interleukin and tumor necrosis factor alpha are associated with fatality in fulminant hepatitis. J Infect Dis, 182(4): 1103–1108.

    Article  CAS  PubMed  Google Scholar 

  11. Pfeffer K T, Matsuyama T M, Kundig A, et al. 1993. Mice deficient for the 55-kD tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell, 73: 457.

    Article  CAS  PubMed  Google Scholar 

  12. Reynolds A, Leake D, Boese Q, et al. 2004. Rational siRNA design for RNA interference. Nat Biotechnol, 22(3): 326–330.

    Article  CAS  PubMed  Google Scholar 

  13. Schomber T, Kalberer C P, Wodnar-Filipowicz A, et al. 2004. Gene silencing by lentivirus-mediated delivery of siRNA in human CD34+ cells. Blood, 103: 4511–4513.

    Article  CAS  PubMed  Google Scholar 

  14. Song E, Lee S K, Wang J, et al. 2003. RNA interference targeting Fas protects mice from fulminant hepatitis. Nat Med, 9(3): 347–351.

    Article  CAS  PubMed  Google Scholar 

  15. Varfolomeev E E, Boldin M P, Goncharov T M, et al. 1996. A potential mechanism of ‘cross-talk’ between the p55 tumor necrosis factor receptor and Fas/APO1: proteins binding to the death domains of the two receptors also bind to each other. J. Exp. Med. 183: 1271–1275.

    Article  CAS  PubMed  Google Scholar 

  16. Zhu C L, Sun Y, Yan W M, et al. 2006. Novel mfgl2 antisense plasmid inhibits mfgl2 expression and ameliorates MHV-3 induced fulminant hepatitis in Balb/cJ mice. Human Gene Therapy, 17: 589–600.

    Article  CAS  PubMed  Google Scholar 

  17. Zaehres H, Lensch M W, Daheron L, et al. 2005. High-efficiency RNA interference in human embryonic stem cells. Stem Cells, 23(3): 299–305.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Qin Ning.

Additional information

Foundation items: National Science Fund of China (NSFC) (30571643, 30672380, 30700702); National Key Basic Research Program of China (2005CB522901, 2007CB 512900).

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gao, S., Wang, M., Guo, Jw. et al. Construction of mTNFR1shRNA plasmid and its biological effects on MHV-3 induced fulminant hepatitis in BALB/cJ mice. Virol. Sin. 25, 52–58 (2010). https://doi.org/10.1007/s12250-010-3072-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12250-010-3072-x

Key words

Navigation